Date published: 2026-7-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

glypican-4 Antibody (AT51E3): sc-517403

5.0(1)
Write a reviewAsk a question

Datasheets
  • glypican-4 Antibody (AT51E3) is a mouse monoclonal IgG2a κ glypican-4 antibody provided at 100 µg/ml
  • raised against a recombinant protein corresponding to amino acids 401-529 of glypican-4 of human origin
  • recommended for detection of glypican-4 of human origin by WB, IF, FCM and ELISA
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for glypican-4 Antibody (AT51E3). This work is in progress.
Gene Editing Promo Banner

QUICK LINKS

SEE ALSO...

glypican-4 Antibody (AT51E3) is a mouse monoclonal IgG2a kappa light chain antibody that detects the glypican-4 protein of human origin by western blotting (WB), immunofluorescence (IF), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). anti-glypican-4 antibody (AT51E3) is available as a non-conjugated format. Glypican-4, also known as K-glypican, is a 556 amino acid cell surface proteoglycan that plays a crucial role in the development of the central nervous system and the formation of kidney tubules. Glypican-4 is anchored to the cell membrane via a glycosylphosphatidylinositol moiety and is involved in regulating cell growth and division through interaction with various signaling molecules. Notably, glypican-4 is implicated in the modulation of fibroblast growth factor 2 (FGF-2) activity during cortical neurogenesis, highlighting its importance in neural development. Following proteolytic cleavage, glypican-4 is released into the extracellular space, where glypican-4 can influence cellular signaling pathways. The gene encoding glypican-4 is located on human chromosome Xq26.2 and mouse chromosome X A5, and glypican-4 deletion has been associated with Simpson-Golabi-Behmel syndrome, an X-linked condition that shares clinical features with Beckwith-Wiedemann syndrome. This makes glypican-4 not only a significant marker for research but also a potential target for understanding developmental disorders.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

glypican-4 Antibody (AT51E3) References:

  1. Expression of glypican-4 in haematopoietic-progenitor and bone-marrow-stromal cells.  |  Siebertz, B., et al. 1999. Biochem J. 344 Pt 3: 937-43. PMID: 10585884
  2. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.  |  Veugelers, M., et al. 2000. Hum Mol Genet. 9: 1321-8. PMID: 10814714
  3. Glypican-4 is an FGF2-binding heparan sulfate proteoglycan expressed in neural precursor cells.  |  Hagihara, K., et al. 2000. Dev Dyn. 219: 353-67. PMID: 11066092
  4. Cell surface glypicans are low-affinity endostatin receptors.  |  Karumanchi, SA., et al. 2001. Mol Cell. 7: 811-22. PMID: 11336704
  5. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney.  |  Watanabe, K., et al. 1995. J Cell Biol. 130: 1207-18. PMID: 7657705
  6. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.  |  Veugelers, M., et al. 1998. Genomics. 53: 1-11. PMID: 9787072
  7. Glypican 3 and glypican 4 are juxtaposed in Xq26.1.  |  Huber, R., et al. 1998. Gene. 225: 9-16. PMID: 9931407

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

glypican-4 Antibody (AT51E3)

sc-517403
100 µg/ml
$322.00